LIGAND PHARMACEUTICALS INCORPORATED Deferred Tax Liabilities, Tax Deferred Income
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Deferred Tax Liabilities, Tax Deferred Income of $3.49 million as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome · last filed 2020-02-27
- 2019-12-31: Deferred Tax Liabilities, Tax Deferred Income $3.49M.
- 2018-12-31: Deferred Tax Liabilities, Tax Deferred Income $0.00.
| Period end | Deferred Tax Liabilities, Tax Deferred Income |
|---|---|
| 2019-12-31 | $3.49M 10-K · filed 2020-02-27 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |